(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

IPONATIC

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

IPONATIC

ST13

US500000079360563

Class

5, 9, 10

Filing

79360563

Registration

7341783

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

30

Latest update

11/09/2024

Trademark type

Combined

Nice classes

5, 9, 10

Filing date

10/09/2022

Registration date

04/02/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/02/2024

Last transaction

04/02/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

5

Owner type

03

Owner location

CN

Examiner

PERITZ, SARAH

Law office

O20

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Sansure Biotech Inc.

Representatives

Yue (Robert) Xu Apex Attorneys at Law, LLP

Technical classification

Nice Classes

Class 5Class 9Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Injectable pharmaceuticals for treatment of anaphylactic reactions; Metallic compounds for consumption and/or injection for use in medical imaging and for diagnostic purposes; Vaccines; Antibiotic tablets; Allergy tablets; Mineralvitaminnutritionally enhanced water for medical purposes; Medicated water for the treatment of illnesses attributed to insufficient cellular energy; Medicated water for the treatment of allergiescoughcoldfluheadachepain; Medicated water for the treatment of infectious diseasesskin diseases and conditionsinternal diseases and conditions; Medicated water for the treatment of painnausea and muscle spasms; Medicated water-based solutions in the nature of serums for treating skin infections and skin conditions; Medicated water for the treatment of gastrointestinal disorders; Demineralised water for medical purposes; Antibiotic ointments; Anti-inflammatory ointments; Medicated ointments for treating dermatological conditions; Chinese medicine nostrum in the nature of natural remedy preparationmedicinal herbs; Diagnostic kits comprised of medical diagnostic reagents for testing of bodily fluids for use in disease testinghealth monitoringpredictive and preventive medicine in the fields of detecting immune system and respiratory system diseasescancerinfectious diseasesinflammatory disordersoncological disorders; Purified biochemical medical diagnostic reagentsprotein arrays for medical diagnosis purposesenzymes for medical purposesfluorescent surgical dyes; Biological preparations for the treatment of disorders of the nervous systemthe immune systemthe cardio-vascular systemthe metabolic systemthe respiratory systemthe musculo-skeletal systemthe genitourinary systeminflammatory disordersdermatological conditionsoncological diseasesblood diseasesconnective tissue disordersophthalmic diseasesgastroenterological disorders; Biochemical drugs in the nature of biochemical drug delivery systems comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents for the treatment of disorders of the nervous systemthe immune systemthe cardiovascular systemthe metabolic systemthe respiratory systemthe musculo-skeletal systemthe genitourinary systeminflammatory disordersdermatological conditionsoncological diseasesblood diseasesconnective tissue disordersophthalmic diseasesgastroenterological disorders; Diagnostic preparations for medical purposes; Chemical-pharmaceutical preparations in the nature of biological indicatorsin-vivo diagnostic agentsin-vitro diagnostic reagents for the diagnosismonitoringtreatment and prevention of cancerinflammatory disordersoncological disordersinfectious diseasesdiseases related to the immune system and respiratory system; Chemical preparations in the nature of biological indicatorsin-vivo diagnostic agentsin-vitro diagnostic reagents for the diagnosismonitoringtreatment and prevention of cancerinflammatory disordersoncological disordersinfectious diseasesdiseases related to the immune system and respiratory systems; Preparations for detecting mutation in prion genes for medical purposes; Chemical reagents for medical or veterinary purposes; Reagents for medical use; Reagents for use in medical genetic testing; Medical diagnostic reagents; Enzyme preparations for medical purposes; Diagnostic biomarker reagents for medical purposes; Rat poison; Medical dressings; Materials for artificial teeth; Diapers for pets; Reagent paper for medical purposes; Chemical preparations for the diagnosis of pregnancy; Preparations for detecting genetic predispositions for medical purposes; Immunoassay reagents for medical use; Genetic identity tests comprised of reagents for medical purposes; Cultures of microorganisms for medical or veterinary use; Diagnostic preparations for veterinary purposes

Class 9

Downloadable computer operating programs; Recorded computer operating software; Downloadable software application for mobile phonesdownloadable software for use in operating polymerase chain reaction (PCR) instruments; Downloadable software application for mobile phonesdownloadable software for DNA and gene analysis; Data processing apparatus; Biometric scanners; Chemistry apparatus and instrumentsliquid test tubes and containers in the nature of laboratory glassware beakerssolvent reservoirschromatography columns for laboratory use; Chromatography apparatus for laboratory use; MRI apparatusnot for medical purposes; Automatic ion exchange chromatography apparatus for laboratory use; Polymerase chain reaction (PCR) instruments for use in scientific researchlaboratory apparatus and instruments for amplifying DNA using polymerase chain reactionnot for medical purposes; DNA chips; Electronic devices for analyzing genome information for laboratory use; Nucleic acid sequencers for scientific purposes; Laboratory devices for detecting genetic sequences; Bio-chips for research or scientific purposes

Class 10

Apparatus for DNA and RNA testing for medical purposes; Blood testing apparatus; Probes for medical purposes; analysers for bacterial identification for medical purposes; Diagnostic apparatus for medical purposes in the nature of medical diagnostic imaging apparatus for use with computer displays and computer monitors for use with recorded computer operating software and recorded smartphone operating softwareall sold as a unit; Medical equipmentdevices for bioanalysis of pathogens in the nature of reagent cartridges for sample preparationnucleic acid purificationnucleic acid amplification and electrochemical detection for medical diagnostic purposes; Surgical apparatus and instruments; Genetic testing apparatus for medical purposes; Apparatus for use in medical analysisapparatus for blood analysisbody composition analyzersapparatus for analyzing and detecting bacteria and virusesapparatus for analyzing and detecting DNA and RNAapparatus for analyzing and detecting genesapparatus for analyzing blood vesselsapparatus for cavitation detectingapparatus for imaging analysis; Body composition analyzers for medical purposes; Radiotherapy apparatus; Physiotherapy apparatusbody rehabilitation apparatus for medical use; Lasers for medical purposes; Orthopaedic belts; Orthopaedic bandages; Orthopaedic footwear; Suture materials

Publications

History of USPTO decisions and trademark events.

30 publications found

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

11/09/2024

FICS

FINAL DISPOSITION NOTICE SENT TO IB

10/17/2024

FIMP

FINAL DISPOSITION PROCESSED

10/17/2024

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

07/03/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

04/02/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

04/02/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/16/2024

PUBO

PUBLISHED FOR OPPOSITION

01/16/2024

GPNX

NOTIFICATION PROCESSED BY IB

01/13/2024

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

12/27/2023

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

12/27/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/27/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/14/2023

XAEC

EXAMINER'S AMENDMENT ENTERED

12/14/2023

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

12/14/2023

GNEA

EXAMINERS AMENDMENT E-MAILED

12/14/2023

CNEA

EXAMINERS AMENDMENT -WRITTEN

12/14/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/20/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/17/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/17/2023

RFNT

REFUSAL PROCESSED BY IB

09/13/2023

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

08/21/2023

RFRR

REFUSAL PROCESSED BY MPU

08/21/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

07/27/2023

CNRT

NON-FINAL ACTION WRITTEN

07/26/2023

DOCK

ASSIGNED TO EXAMINER

07/24/2023

MAFR

APPLICATION FILING RECEIPT MAILED

01/31/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/25/2023

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

01/23/2023

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

01/19/2023

Continuous trademark protection

Get notified about every new filing that threatens IPONATIC or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.